Cite
Myricetin ameliorates the severity of pancreatitis in mice by regulating cathepsin B activity and inflammatory cytokine production.
MLA
Choi, Ji-Won, et al. “Myricetin Ameliorates the Severity of Pancreatitis in Mice by Regulating Cathepsin B Activity and Inflammatory Cytokine Production.” International Immunopharmacology, vol. 136, July 2024, p. 112284. EBSCOhost, https://doi.org/10.1016/j.intimp.2024.112284.
APA
Choi, J.-W., Shin, J., Zhou, Z., Song, H.-J., Bae, G.-S., Kim, M. S., & Park, S.-J. (2024). Myricetin ameliorates the severity of pancreatitis in mice by regulating cathepsin B activity and inflammatory cytokine production. International Immunopharmacology, 136, 112284. https://doi.org/10.1016/j.intimp.2024.112284
Chicago
Choi, Ji-Won, Joonyeon Shin, Ziqi Zhou, Ho-Joon Song, Gi-Sang Bae, Min Seuk Kim, and Sung-Joo Park. 2024. “Myricetin Ameliorates the Severity of Pancreatitis in Mice by Regulating Cathepsin B Activity and Inflammatory Cytokine Production.” International Immunopharmacology 136 (July): 112284. doi:10.1016/j.intimp.2024.112284.